investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Biotechnology Engagement Program (BTEP) Supporting Scientific Redirection Through the Engagement of CIS Former Biological Weapons Scientists in Public Health Related Research Working in Collaboration with U.S. Scientists
John Beulter
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Microbial synthesis of new medicine preparation and Anti-Tumor Activity and Anti-viral Activity
Related projects
Titia De Lange
The role of telomere-related tetraploidization in cancer
All cancers but non-melanoma skin cancer
Piotr Sliz
Structural and Mechanistic Studies of Regulation of let-7 biogenesis by Lin28
All cancers but non-melanoma skin cancer
Peter J. Murray
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
All cancers but non-melanoma skin cancer
Daniel McVicar
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
All cancers but non-melanoma skin cancer
Pathology
Frank Gonzalez
Xenobiotic-Metabolizing Enzymes
All cancers but non-melanoma skin cancer
Gregory A Lizee
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
All cancers but non-melanoma skin cancer
William Figg
Development of Angiogenesis Inhibitors
All cancers but non-melanoma skin cancer
Masanobu Komatsu
Normalization of Tumor Vasculature by R-Ras
All cancers but non-melanoma skin cancer
David Roberts
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
All cancers but non-melanoma skin cancer